-
Je něco špatně v tomto záznamu ?
Neonatal administration of N-acetyl-L-aspartyl-L-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats
Bubeníková-Valesová V, Balcar VJ, Tejkalová H, Langmeier M, St'astný F.
Jazyk angličtina Země Velká Británie
- MeSH
- chování zvířat účinky léků MeSH
- dipeptidy aplikace a dávkování fyziologie MeSH
- financování organizované MeSH
- fragmentace DNA MeSH
- hipokampus patologie růst a vývoj účinky léků MeSH
- injekce intraventrikulární MeSH
- koncové značení zlomů DNA in situ MeSH
- krysa rodu rattus MeSH
- neurodegenerativní nemoci chemicky indukované patofyziologie patologie MeSH
- neurony patologie účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
N-acetyl-L-aspartyl-L-glutamate (NAAG) is a dipeptide that could be considered a sequestered form of L-glutamate. As much as 25% of L-glutamate in brain may be present in the form of NAAG. NAAG is also one of the most abundant neuroactive small molecules in the CNS: it is an agonist at Group II metabotropic glutamate receptors (mGluR II) and, at higher concentrations, at the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptors. As such, NAAG can be either neuroprotective or neurotoxic and, in fact, both characteristics have been discussed and described in the literature. In the present studies, 250 nmol NAAG was infused into each lateral cerebral ventricle of 12-day-old rat pups and, using Nissl-stained sections, neurodegeneration in the hippocampus was evaluated 24 or 96 h after the infusion. In several experiments, the neuronal death was also visualised by Fluoro-Jade B staining and studied by TUNEL technique. Some of the NAAG-treated animals were allowed to survive until 50 days post partum and subjected to behavioural (open field) tests. The administration of NAAG to 12-day-old rats resulted in extensive death of neurons particularly in the dentate gyrus of the hippocampus. The neurodegeneration was, in part, prevented by administration of an NMDA receptor antagonist MK-801 (0.1 mg/kg). The nuclear DNA-fragmentation demonstrated by TUNEL technique pointed to the presence of non-specific single-strand DNA cleavage. The NAAG-associated neonatal neuronal damage may have perturbed development of synaptic circuitry during adolescence as indicated by an altered performance of the experimental animals in the open field testing (changes in grooming activity) at postnatal day 50. The results underscore the potential neurotoxicity of NAAG in neonatal rat brain and implicate neonatally induced, NMDA receptor-mediated neuronal loss in the development of abnormal behaviour in young adult rats.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07521895
- 003
- CZ-PrNML
- 005
- 20111210133022.0
- 008
- 090422s2006 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Valešová, Věra, $d 1977- $7 nlk20050173200
- 245 10
- $a Neonatal administration of N-acetyl-L-aspartyl-L-glutamate induces early neurodegeneration in hippocampus and alters behaviour in young adult rats / $c Bubeníková-Valesová V, Balcar VJ, Tejkalová H, Langmeier M, St'astný F.
- 314 __
- $a Prague Psychiatric Centre Affiliated with Third Faculty of Medicine & Centre of Neuropsychiatric Studies, 181 03 Prague 8, Czech Republic
- 520 9_
- $a N-acetyl-L-aspartyl-L-glutamate (NAAG) is a dipeptide that could be considered a sequestered form of L-glutamate. As much as 25% of L-glutamate in brain may be present in the form of NAAG. NAAG is also one of the most abundant neuroactive small molecules in the CNS: it is an agonist at Group II metabotropic glutamate receptors (mGluR II) and, at higher concentrations, at the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptors. As such, NAAG can be either neuroprotective or neurotoxic and, in fact, both characteristics have been discussed and described in the literature. In the present studies, 250 nmol NAAG was infused into each lateral cerebral ventricle of 12-day-old rat pups and, using Nissl-stained sections, neurodegeneration in the hippocampus was evaluated 24 or 96 h after the infusion. In several experiments, the neuronal death was also visualised by Fluoro-Jade B staining and studied by TUNEL technique. Some of the NAAG-treated animals were allowed to survive until 50 days post partum and subjected to behavioural (open field) tests. The administration of NAAG to 12-day-old rats resulted in extensive death of neurons particularly in the dentate gyrus of the hippocampus. The neurodegeneration was, in part, prevented by administration of an NMDA receptor antagonist MK-801 (0.1 mg/kg). The nuclear DNA-fragmentation demonstrated by TUNEL technique pointed to the presence of non-specific single-strand DNA cleavage. The NAAG-associated neonatal neuronal damage may have perturbed development of synaptic circuitry during adolescence as indicated by an altered performance of the experimental animals in the open field testing (changes in grooming activity) at postnatal day 50. The results underscore the potential neurotoxicity of NAAG in neonatal rat brain and implicate neonatally induced, NMDA receptor-mediated neuronal loss in the development of abnormal behaviour in young adult rats.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chování zvířat $x účinky léků $7 D001522
- 650 _2
- $a fragmentace DNA $7 D053938
- 650 _2
- $a dipeptidy $x aplikace a dávkování $x fyziologie $7 D004151
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hipokampus $x patologie $x růst a vývoj $x účinky léků $7 D006624
- 650 _2
- $a koncové značení zlomů DNA in situ $7 D020287
- 650 _2
- $a injekce intraventrikulární $7 D007276
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a neurodegenerativní nemoci $x chemicky indukované $x patofyziologie $x patologie $7 D019636
- 650 _2
- $a neurony $x patologie $x účinky léků $7 D009474
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Balcar, V. J.
- 700 1_
- $a Tejkalová, Hana, $d 1948- $7 xx0070846
- 700 1_
- $a Langmeier, Miloš, $d 1951- $7 jn20000710407
- 700 1_
- $a Šťastný, František, $d 1942- $7 xx0002050
- 773 0_
- $w MED00003485 $t Neurochemistry international $g Roč. 48, č. 6-7 (2006), s. 515-522 $x 0197-0186
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090312170439 $b ABA008
- 991 __
- $a 20090717114512 $b ABA008
- 999 __
- $a ok $b bmc $g 644984 $s 497900
- BAS __
- $a 3
- BMC __
- $a 2006 $b 48 $c 6-7 $d 515-522 $i 0197-0186 $m Neurochemistry international $x MED00003485
- LZP __
- $a 2009-B1/vtme